narmac - I hear you. I'm down too, as I'm sure are others. But, that doesn't mean it's the end of the road.  If the stock went back up to even $2 then there would have to be a good reason for it, and then begs the question as to whether or not to bail or wait. The politics of extensive foreign ownership could be an issue, but we don't really know for sure. Management could be an issue, and I agree there are some valid points that have been made on this, but we still don't know everything that goes on behind the public announcements. So, what does that leave?

For me it's apabetalone or, more generally, the science.  Is this product a medically viable game changer or not?  The groundwork in the scientific community is being laid through publications in noteworthy journals.  RVX seems to be doing a great job with establishing credibility on that front.  The business side may be lacking, but somehow or other there will be a BoM2.  Covid has absolutely slowed progress on that but maybe Covid presents RVX will a silver lining to compensate for it.  

Hang in there narmac, other than sell there's not much else we can do.